Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERACYTE, INC.VCYT · Entity 2018 | EVP, General Counsel | September 02, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERACYTE, INC.
Report date September 02, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,414 |
Reported balance
After 2026-09-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-02 · Tax withholding · Disposed 3,215 · Balance 134,414 F1: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. F2: Includes 389 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | Direct | 132,260 |
Reported balance
After 2026-09-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-04 · Sale · Disposed 2,154 · Balance 132,260 F3: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F4: Represents weighted average sales price. Sale prices for the transactions range from $42.49 to $43.38. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
| Common StockSEC Table I · non-derivative | Direct | 131,160 |
Reported balance
After 2026-09-04 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-09-04 · Sale · Disposed 1,100 · Balance 131,160 F3: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F5: Represents weighted average sales price. Sale prices for the transactions range from $43.50 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.
F2: Includes 389 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
F3: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025.
F4: Represents weighted average sales price. Sale prices for the transactions range from $42.49 to $43.38. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F5: Represents weighted average sales price. Sale prices for the transactions range from $43.50 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2026 Filed Sep 4, 2026 23:54 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,100 | $43.67 | $48,038.98 |
DisclosureSEC source: 0001914620-26-000013 · wk-form4_1788566040.xml · nonDerivative · entry 3 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,160 F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F5 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.50 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 04, 2026 Filed Sep 4, 2026 23:54 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,154 | $42.79 | $92,173.11 |
DisclosureSEC source: 0001914620-26-000013 · wk-form4_1788566040.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 132,260 F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.49 to $43.38. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 23:54 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 3,215 | $44.88 | $144,289.20 |
DisclosureSEC source: 0001914620-26-000013 · wk-form4_1788566040.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,414 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. F2 · balance_after: Includes 389 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,776 | $50.12 | $89,007.44 |
DisclosureSEC source: 0001914620-26-000011 · wk-form4_1780623529.xml · nonDerivative · entry 3 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,240 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $49.89 to $50.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,400 | $49.31 | $69,028.54 |
DisclosureSEC source: 0001914620-26-000011 · wk-form4_1780623529.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,016 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $48.84 to $49.84. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 3,292 | $47.80 | $157,357.60 |
DisclosureSEC source: 0001914620-26-000011 · wk-form4_1780623529.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,416 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale. Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:25 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 5,102 | $40.00 | $204,080.00 |
DisclosureSEC source: 0001914620-26-000010 · wk-form4_1778271897.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,708 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. Read SEC document |
| May 06, 2026 Filed May 8, 2026 20:25 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 5,102 | $38.05 | $194,131.10 |
DisclosureSEC source: 0001914620-26-000010 · wk-form4_1778271897.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,810 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 26,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001914620-26-000008 · wk-form4_1773177022.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,912 F2 · kind: Restricted stock units awarded on March 6, 2026 vest in full on the first anniversary of the date of grant subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 32,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001914620-26-000008 · wk-form4_1773177022.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,598 F1 · kind: Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:32 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,664 | $36.34 | $60,468.60 |
DisclosureSEC source: 0001914620-26-000006 · wk-form4_1772832761.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,706 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $36.17 to $36.48. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:32 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 4,994 | $35.29 | $176,256.24 |
DisclosureSEC source: 0001914620-26-000006 · wk-form4_1772832761.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,370 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 6,902 | $36.01 | $248,541.02 |
DisclosureSEC source: 0001914620-26-000004 · wk-form4_1772659026.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,364 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 10,867 | $38.75 | $421,096.25 |
DisclosureSEC source: 0001914620-26-000002 · wk-form4_1772488366.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,266 F3 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 50,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001914620-26-000002 · wk-form4_1772488366.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,133 F1 · kind: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 21,071 PSUs vested on February 26, 2026, and the remaining 29,928 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date. F2 · balance_after: Includes 374 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 100 | $43.68 | $4,368.00 |
DisclosureSEC source: 0001914620-25-000012 · wk-form4_1766007307.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,760 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 21:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 10,639 | $43.13 | $458,835.60 |
DisclosureSEC source: 0001914620-25-000012 · wk-form4_1766007307.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,860 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.62 to $43.59. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 702 | $47.51 | $33,352.02 |
DisclosureSEC source: 0001914620-25-000010 · wk-form4_1764895458.xml · nonDerivative · entry 3 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,499 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 720 | $47.10 | $33,908.76 |
DisclosureSEC source: 0001914620-25-000010 · wk-form4_1764895458.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,201 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $46.50 to $47.48. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:44 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 3,052 | $46.16 | $140,880.32 |
DisclosureSEC source: 0001914620-25-000010 · wk-form4_1764895458.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,921 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 6,466 | $40.00 | $258,640.00 |
DisclosureSEC source: 0001914620-25-000008 · wk-form4_1762549830.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,973 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,160 | $35.00 | $75,607.56 |
DisclosureSEC source: 0001914620-25-000006 · wk-form4_1759522563.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,439 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.05. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 20:18 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,283 | $33.69 | $76,919.52 |
DisclosureSEC source: 0001914620-25-000004 · wk-form4_1758658718.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,599 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $33.50 to $34.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:18 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 3,507 | $30.11 | $105,595.77 |
DisclosureSEC source: 0001384101-25-000120 · wk-form4_1757020678.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,882 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale. F2 · balance_after: Includes 386 shares of common stock purchased on July 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 21:01 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 3,505 | $26.74 | $93,723.70 |
DisclosureSEC source: 0001384101-25-000072 · wk-form4_1749070896.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,003 F1 · kind: The reporting person is reporting the withholding of 726, 453, 743 and 1,583 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,428, 892, 1,463 and 3,117 Restricted Stock Units granted on February 28, 2022, August 5, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:43 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 30,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-25-000041 · wk-form4_1741639413.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,508 F1 · kind: Restricted stock units awarded on March 6, 2025 vest 25% on March 2, 2026 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:41 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,142 | $33.69 | $38,476.49 |
DisclosureSEC source: 0001384101-25-000030 · wk-form4_1741297299.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,308 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $33.5 to $34.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 02, 2025 Filed Mar 3, 2025 21:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 8,255 | $34.76 | $286,943.80 |
DisclosureSEC source: 0001384101-25-000021 · wk-form4_1741037387.xml · nonDerivative · entry 3 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,450 F4 · kind: The reporting person is reporting the withholding of 726, 453, 743 and 6,333 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,429, 892, 1,463 and 12,470 Restricted Stock Units granted on February 28, 2022, August 5, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 7,000 | $33.84 | $236,880.00 |
DisclosureSEC source: 0001384101-25-000021 · wk-form4_1741037387.xml · nonDerivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,705 F3 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 13,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-25-000021 · wk-form4_1741037387.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,705 F1 · kind: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. F2 · balance_after: Includes 370 shares of common stock purchased on January 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:34 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 18,699 | $44.02 | $823,178.60 |
DisclosureSEC source: 0001384101-24-000185 · wk-form4_1733520875.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,869 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $43.46 to $44.46. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:59 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,918 | $44.12 | $84,622.16 |
DisclosureSEC source: 0001384101-24-000182 · wk-form4_1733349583.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,568 F1 · kind: The reporting person is reporting the withholding of 724, 452 and 742 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,428, 891 and 1,464 Restricted Stock Units granted on February 28, 2022, August 5, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,920 | $31.55 | $60,576.00 |
DisclosureSEC source: 0001384101-24-000150 · wk-form4_1725489929.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,486 F1 · kind: The reporting person is reporting the withholding of 725, 453 and 742 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,429, 892 and 1,463 Restricted Stock Units granted on February 28, 2022, August 5, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2024 Filed Jun 4, 2024 20:43 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,919 | $20.75 | $39,819.25 |
DisclosureSEC source: 0001384101-24-000078 · wk-form4_1717533785.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,406 F1 · kind: The reporting person is reporting the withholding of 724, 453 and 742 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,428, 892 and 1,463 Restricted Stock Units granted on February 28, 2022, August 5, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:37 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 49,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-24-000039 · wk-form4_1709933817.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,325 F1 · kind: Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 02, 2024 Filed Mar 5, 2024 22:29 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 4,347 | $24.00 | $104,328.00 |
DisclosureSEC source: 0001384101-24-000029 · wk-form4_1709677754.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,445 F1 · kind: The reporting person is reporting the withholding of 800, 500 and 3,047 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,429, 892 and 5,853 Restricted Stock Units granted on February 28, 2022, August 5, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| December 02, 2023 Filed Dec 5, 2023 21:45 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 803 | $26.54 | $21,311.62 |
DisclosureSEC source: 0001384101-23-000173 · wk-form4_1701812731.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,792 F1 · kind: The reporting person is reporting the withholding of 494 and 309 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,428 and 891 Restricted Stock Units granted on February 28, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person. Read SEC document |
| September 02, 2023 Filed Sep 6, 2023 20:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,729 | $26.70 | $46,164.30 |
DisclosureSEC source: 0001384101-23-000150 · wk-form4_1694032529.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,595 F1 · kind: The reporting person is reporting the withholding of 495 and 1,234 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,429 and 3,568 Restricted Stock Units granted on February 28, 2022 and August 5, 2022, respectively, and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 20:48 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 494 | $26.72 | $13,199.68 |
DisclosureSEC source: 0001384101-23-000079 · wf-form4_168608446990009.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,324 F1 · kind: The reporting person is reporting the withholding of 494 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,428 Restricted Stock Units granted on February 28, 2022 and does not represent a sale by the reporting person. Read SEC document |
| March 06, 2023 Filed Mar 10, 2023 00:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 38,660 | $0.00 Strike: $23.73 | $0.00 |
DisclosureSEC source: 0001384101-23-000037 · wf-form4_167840699884520.xml · derivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,660 Underlying: Common Stock · 38,660 shares Expires 2033-03-06 F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2024, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| March 06, 2023 Filed Mar 10, 2023 00:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 23,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-23-000037 · wf-form4_167840699884520.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,818 F1 · kind: Restricted stock units awarded on March 6, 2023 vest 25% on March 2, 2024 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 02, 2023 Filed Mar 4, 2023 01:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,152 | $24.10 | $51,863.20 |
DisclosureSEC source: 0001384101-23-000026 · wf-form4_167789218003899.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,405 F1 · kind: The reporting person is reporting the withholding of 2,152 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 5,713 Restricted Stock Units granted on February 28, 2022 and does not represent a sale by the reporting person. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 18,248 | $0.00 Strike: $27.90 | $0.00 |
DisclosureSEC source: 0001384101-22-000117 · wf-form4_166007992573625.xml · derivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,248 Underlying: Common Stock · 18,248 shares Expires 2032-08-05 F2 · derivative.exercise_date: The option becomes exercisable as to 1/3rd of the shares on August 5, 2023, and the remaining shares vest at a rate of 1/36th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 21:19 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 10,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000117 · wf-form4_166007992573625.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,557 F1 · kind: Restricted stock units awarded on August 5, 2022 vest 1/3rd on September 2, 2023 and 1/12th per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 02:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 42,175 | $0.00 Strike: $27.80 | $0.00 |
DisclosureSEC source: 0001384101-22-000034 · wf-form4_164627312110088.xml · derivative · entry 2 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,175 Underlying: Common Stock · 42,175 shares Expires 2032-02-28 F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 02:05 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 22,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000034 · wf-form4_164627312110088.xml · nonDerivative · entry 1 McGuire Annie · CIK 0001914620 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,855 F1 · kind: Restricted stock units awarded on February 28, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.